prednisolone has been researched along with Muscular Dystrophies, Limb-Girdle in 3 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Muscular Dystrophies, Limb-Girdle: A heterogenous group of inherited muscular dystrophy that can be autosomal dominant or autosomal recessive. There are many forms (called LGMDs) involving genes encoding muscle membrane proteins such as the sarcoglycan (SARCOGLYCANS) complex that interacts with DYSTROPHIN. The disease is characterized by progressing wasting and weakness of the proximal muscles of arms and legs around the HIPS and SHOULDERS (the pelvic and shoulder girdles).
| Excerpt | Relevance | Reference |
|---|---|---|
| "An 11-year-old girl with a calpain-3 gene (CAPN-3) mutation and eosinophilic myositis on muscle biopsy had high serum CK levels and eosinophil counts which showed spontaneous fluctuations." | 7.75 | Eosinophilic myositis in calpainopathy: could immunosuppression of the eosinophilic myositis alter the early natural course of the dystrophic disease? ( Dincer, P; Gundesli, H; Oflazer, PS; Sabuncu, T; Zorludemir, S, 2009) |
| "An 11-year-old girl with a calpain-3 gene (CAPN-3) mutation and eosinophilic myositis on muscle biopsy had high serum CK levels and eosinophil counts which showed spontaneous fluctuations." | 3.75 | Eosinophilic myositis in calpainopathy: could immunosuppression of the eosinophilic myositis alter the early natural course of the dystrophic disease? ( Dincer, P; Gundesli, H; Oflazer, PS; Sabuncu, T; Zorludemir, S, 2009) |
| "Eosinophilia has been reported previously in patients with Calpainopathy and Becker Muscular Dystrophy and might be an early, but transient feature of a wider range of muscular dystrophies." | 1.35 | Eosinophilic myositis as presenting symptom in gamma-sarcoglycanopathy. ( Baumeister, SK; Dekomien, G; Lochmüller, H; Milić-Rasić, V; Todorovic, S; Walter, MC, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Madokoro, Y | 1 |
| Kato, H | 1 |
| Yuasa, H | 1 |
| Ootaka, N | 1 |
| Mori, Y | 1 |
| Mitake, S | 1 |
| Baumeister, SK | 1 |
| Todorovic, S | 1 |
| Milić-Rasić, V | 1 |
| Dekomien, G | 1 |
| Lochmüller, H | 1 |
| Walter, MC | 1 |
| Oflazer, PS | 1 |
| Gundesli, H | 1 |
| Zorludemir, S | 1 |
| Sabuncu, T | 1 |
| Dincer, P | 1 |
3 other studies available for prednisolone and Muscular Dystrophies, Limb-Girdle
| Article | Year |
|---|---|
[A case of eosinophilic myositis presenting with myocarditis and cardiac embolism].
Topics: Administration, Oral; Aged; Anticoagulants; Brain; Diffusion Magnetic Resonance Imaging; Electrocard | 2015 |
Eosinophilic myositis as presenting symptom in gamma-sarcoglycanopathy.
Topics: Anti-Inflammatory Agents; Biopsy; Disease Progression; DNA Mutational Analysis; Eosinophilia; Female | 2009 |
Eosinophilic myositis in calpainopathy: could immunosuppression of the eosinophilic myositis alter the early natural course of the dystrophic disease?
Topics: Azathioprine; Calpain; Child; Creatine Kinase; Disease Progression; Dose-Response Relationship, Drug | 2009 |